Table 3. Results of the Multivariable... | American Society of Hematology

Table 3.

Results of the Multivariable Analyses

Group	Parameter	Favorable	Leukemia-Free Survival			Nonleukemic Death			Relapse
			RR^3-150	95% CI	P Value	RR	95% CI	P Value	RR	95% CI	P Value
All patients (n = 174)	Status	Remission	.5	.3-.7	.0001	—	—	NS	.3	.2-.5	.0001
	Cell dose	>3.65^3-151	.6	.5-.9	.01	.5	.3-.8	.003	—	—	NS
	Patient CMV status	Seronegative	.7	.5-1.0	.05	—	—	NS	—	—	NS
	HLA-matching	Mismatch	—	—	NS	—	—	NS	.5	.3-.9	.03
Remission (n = 66)	Cell dose	>3.65^3-151	.3	.2-.6	.0009	.2	.1-.4	.0001	—	—	NS
Relapse (n = 94)	Blasts in PB	None	2.5	1.7-5.0	.0001	3.3	1.4-10.0	.002	—	—	NS
	Blasts in BM	<30%	—	—	NS	—	—	NS	.4	.2-.8	.01
	Relapse no.	REL1 + REL2	—	—	NS	—	—	NS	2.5	1.2-5.0	.01

Group	Parameter	Favorable	Leukemia-Free Survival			Nonleukemic Death			Relapse
			RR^3-150	95% CI	P Value	RR	95% CI	P Value	RR	95% CI	P Value
All patients (n = 174)	Status	Remission	.5	.3-.7	.0001	—	—	NS	.3	.2-.5	.0001
	Cell dose	>3.65^3-151	.6	.5-.9	.01	.5	.3-.8	.003	—	—	NS
	Patient CMV status	Seronegative	.7	.5-1.0	.05	—	—	NS	—	—	NS
	HLA-matching	Mismatch	—	—	NS	—	—	NS	.5	.3-.9	.03
Remission (n = 66)	Cell dose	>3.65^3-151	.3	.2-.6	.0009	.2	.1-.4	.0001	—	—	NS
Relapse (n = 94)	Blasts in PB	None	2.5	1.7-5.0	.0001	3.3	1.4-10.0	.002	—	—	NS
	Blasts in BM	<30%	—	—	NS	—	—	NS	.4	.2-.8	.01
	Relapse no.	REL1 + REL2	—	—	NS	—	—	NS	2.5	1.2-5.0	.01

Abbreviations: BM, bone marrow; CI, confidence interval; CMV, cytomegalovirus; CR, complete remission; n, number; NS, not significant; PB, peripheral blood; REL1, first relapse; REL2, second relapse; RR, relative risk.

F3-150

Relative risk refers to treatment failure, relapse or death, adverse feature is considered as RR > 1.

F3-151

Marrow nucleated cells × 10⁸/kg.

View Large

This Feature Is Available To Subscribers Only